3,136 reports of this reaction
2.1% of all DOCETAXEL ANHYDROUS reports
#11 most reported adverse reaction
FATIGUE is the #11 most commonly reported adverse reaction for DOCETAXEL ANHYDROUS, manufactured by Hospira, Inc.. There are 3,136 FDA adverse event reports linking DOCETAXEL ANHYDROUS to FATIGUE. This represents approximately 2.1% of all 152,096 adverse event reports for this drug.
Patients taking DOCETAXEL ANHYDROUS who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for DOCETAXEL ANHYDROUS, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for DOCETAXEL ANHYDROUS:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 3,136 FDA reports for DOCETAXEL ANHYDROUS. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.1% of all adverse event reports for DOCETAXEL ANHYDROUS, making it a notable side effect.
If you experience fatigue while taking DOCETAXEL ANHYDROUS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.